© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
June 15, 2012
In the current critical review we discuss these emerging trends in localized and systemic treatment as well as possible interesting combinations of the two modalities. Finally, we discuss the role of the new systemic agents in non–clear cell RCC.